adminKexing Biopharm’s Innovative Drug GB19 Received Approval From FDA To Conduct Clinical Trials
Recently, GB19 Injection, independently developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm, has officially received an Investigational New Drug (IND) approval notice from the U.S.…
ROVOS: Redefining Smart Wellness with AI Massage Chairs and Shared Economy Innovation
In today’s fast-evolving wellness industry, smart health technologies are reshaping how people relax, recover, and manage stress. Among these innovations, smart massage chairs have emerged as a key category, bridging…